Khunti, N.; Kumar, M.; Datta, M.; Harelimana, J.d.D.; Harms, M.; Albers, D.; Kirchhoff, F.; Münch, J.; Stenger, S.; Buske, C.;
et al. CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma. Int. J. Mol. Sci. 2025, 26, 2024.
https://doi.org/10.3390/ijms26052024
AMA Style
Khunti N, Kumar M, Datta M, Harelimana JdD, Harms M, Albers D, Kirchhoff F, Münch J, Stenger S, Buske C,
et al. CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma. International Journal of Molecular Sciences. 2025; 26(5):2024.
https://doi.org/10.3390/ijms26052024
Chicago/Turabian Style
Khunti, Nupur, Manish Kumar, Moumita Datta, Jean de Dieu Harelimana, Mirja Harms, Dan Albers, Frank Kirchhoff, Jan Münch, Steffen Stenger, Christian Buske,
and et al. 2025. "CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma" International Journal of Molecular Sciences 26, no. 5: 2024.
https://doi.org/10.3390/ijms26052024
APA Style
Khunti, N., Kumar, M., Datta, M., Harelimana, J. d. D., Harms, M., Albers, D., Kirchhoff, F., Münch, J., Stenger, S., Buske, C., & Maity, P. C.
(2025). CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma. International Journal of Molecular Sciences, 26(5), 2024.
https://doi.org/10.3390/ijms26052024